Author: Adam Marcus

Amid lawsuits, toxicology journal corrects four asbestos papers for failure to cite author links to Georgia-Pacific

The journal Inhalation Toxicology has issued a fascinating correction notice covering four articles on various aspects of asbestos exposure by a group of researchers who failed to note their connection to Georgia-Pacific, the industrial giant that became caught up in a deluge of costly lawsuits over the carcinogenic chemical during the 1980s.

As the notice indicates, the ties weren’t mere tangents, but rather involved obvious — and obviously conflicting — relationships: Continue reading Amid lawsuits, toxicology journal corrects four asbestos papers for failure to cite author links to Georgia-Pacific

Not so fast! Journal retracts paper from Boldt group over author hijinks, more

We knew we hadn’t heard the last of Joachim Boldt, whose nearly 90 retractions make him the putative record holder for a single author in this indistinguished club. But we didn’t expect this:

The European Journal of Anaesthesiology has retracted a paper, “Supplemental oxygen reduces serotonin levels in plasma and platelets during colorectal surgery and reduces postoperative nausea and vomiting,” from Boldt’s former colleagues at the Klinikum Ludwigshafen after determining that the authors were trying to hide their association with the disgraced anesthesiologist.

Continue reading Not so fast! Journal retracts paper from Boldt group over author hijinks, more

MD Anderson researcher Aggarwal loses paper in Cancer Letters

Whether it’s a one-off or a sign of things to come, Bharat Aggarwal, the MD Anderson scientist at the center of a blogospheric storm—and an institutional investigation—over the validity of his data, has had a paper withdrawn by the journal Cancer Letters. Continue reading MD Anderson researcher Aggarwal loses paper in Cancer Letters

Duplication forces retraction of paper by group whose work is used to justify prostate-specific antigen (PSA) testing

A dozen years might seem like a publishing eternity, but the European Journal of Cancer has decided to purge a duplicate paper from 2000. The article, on the utility of the prostate-specific antigen (PSA) test for detecting prostate cancer, comes from a group whose work in this area has been widely cited as evidence for the benefits of the highly controversial screening tool.

“Prostate cancer screening in the Tyrol, Austria: experience and results,” by a group of Austrian researchers, has a rather complicated past. It’s been cited 42 times, according to Thomson Scientific’s Web of Knowledge. Here’s the notice, which appeared in a recent issue of the journal: Continue reading Duplication forces retraction of paper by group whose work is used to justify prostate-specific antigen (PSA) testing

Anesthesia journal editor says “if you blow us off, it will be retracted,” and sticks to his word

The Journal of Clinical Anesthesia has retracted a paper by a group of Israeli authors whose study may not have had appropriate ethical approval — or even collected the reported data.

The article, “Accidental venous and dural puncture during epidural analgesia in obese parturients (BMI > 40 kg/m2): three different body positions during insertion,” was published in 2010 by a team from Assaf Harofeh Medical Center, in Zerifin, one of the country’s largest hospitals and an affiliate of Tel Aviv University. Dural puncture is an infrequent but potentially serious complication of labor anesthesia, causing severe headaches and, in rare cases, death if untreated.

According to the retraction notice: Continue reading Anesthesia journal editor says “if you blow us off, it will be retracted,” and sticks to his word

Plagiarism burns authors of fire safety paper

Safety science might not be the most crowded field, nor its eponymous journal the title on every marquee, but here’s a general rule for would-be plagiarists even in relatively obscure publications: Avoid lifting text from government reports and other publicly available references. (Well, don’t plagiarize at all, but you know what we mean.)

Consider: The journal Safety Science is retracting a 2011 paper whose authors evidently failed to adhere to that principle. Here’s the notice for the article, “Agent-based simulation of fire emergency evacuation with fire and human interaction model,” by Yang Peizhong, Wang Xin and Liu Tao, of Shanghai Jiaotong University: Continue reading Plagiarism burns authors of fire safety paper

Cell runs a lengthy correction, rather than retraction, for image problems

The journal Cell has an interesting — and somewhat puzzling — correction this month that we’ll add to our “mega-correction” file.

At issue is a paper, published in October, from the lab of Harvard’s Stephen Elledge, a noted genetics researcher, whose first author is a post-doc there named Michael Emanuele.

According to the notice, Emanuele (singled out, we note) seems to have been rather careless with the images used in the article, titled “Global Identification of Modular Cullin-RING Ligase Substrates”: Continue reading Cell runs a lengthy correction, rather than retraction, for image problems

Rabies paper retracted for plagiarism, and more from the Journal of Clinical Pathology

A cardinal (if oft-broken) rule of headline writing is to avoid the use of question marks. We think it’s particularly important to do so when the potential for ironic misadventure lurks.

To wit: The Journal of Clinical Pathology (JCP) has withdrawn/retracted a 2008 paper by a group of Indian authors (from the National Institute of Mental Health and Neuro Sciences, at Deemed University) whose cliff-hanging title asks the question “Tracking the footprints of the rabies virus: are we any closer to decoding this elusive virus?” Continue reading Rabies paper retracted for plagiarism, and more from the Journal of Clinical Pathology

MD Anderson investigating researcher Bharat Aggarwal over images

Bharat Aggarwal, an influential MD Anderson researcher who has been accused in the blogosphere of manipulating images in a slew of published studies, acknowledged to Retraction Watch that the Houston institution is investigating the matter. Reached by Retraction Watch by phone at his office, Aggarwal said MD Anderson

has been looking into it and I think that they will tell everybody what it is all about. I think that somebody out there is putting this whole thing together and their mind is made up.

However, Aggarwal, chief of the center’s cytokine research section, denied that any retractions of his papers were forthcoming. He refused to comment on whether officials had confiscated his computer, as a commenter to this blog has claimed. Continue reading MD Anderson investigating researcher Bharat Aggarwal over images

Resveratrol researcher Dipak Das: My lab’s work was “99% correct”

Das, via UConn

Dipak Das, the UConn red wine researcher charged by his institution with rampant misconduct that will likely lead to dozens of retractions, is evidently a 99%-er — when it comes to accuracy, that is.

According to a statement purportedly from his lawyer refuting those charges, Das claims, among other things, that the output from his lab was nearly perfect. He also has a lot to say about a 60,000-page report that the statement says he may not have actually downloaded.

We might note a lot more things about the letter, which we received from Bill Sardi, president of Longevinex, a resveratrol company which has worked with Das. Sardi has been sending Das defenses since the story broke; we posted some of them and Derek Lowe has posted parts of another. But here’s the letter, in its entirety: Continue reading Resveratrol researcher Dipak Das: My lab’s work was “99% correct”